Otologic Pharmaceutics
CompanyUnited States
Otologic Pharmaceutics develops one asset, approved (acetylcysteine). Mostly small molecule acting on Oxidative stress and ROS signalling; based in the United States.
- Assets
- 1
- Furthest
- Approved
- Trials
- 1
- Signals
- 0
Pipeline
1Glutathione precursor and mucolytic agent with antioxidant properties.
ApprovedSmall moleculeOxidative stress and ROS signallingabnormal mucus secretion (Phase 3)acetaminophen overdose (Phase 3)
Full company profiles: pipeline, trials, funding and people.
See Pro- Evidence behind the mechanisms2
- Trials1
- Similar companies6
Updated 7 Oct 2026 · 16 sources